Company profile
AtaiBeckley Inc.
NASDAQ:ATAIBiotechnology: Pharmaceutical Preparations
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05029401 | phase1_2 | completed | 2021-04-01 | 2024-01-16 | atai Therapeutics, Inc. | A Study of Oral Ibogaine in Opioid Withdrawal |
| NCT06524830 | phase2 | recruiting | 2024-12-30 | 2026-08-01 | atai Therapeutics, Inc. | A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA) |
| NCT06693609 | phase2 | completed | 2025-05-08 | 2025-12-10 | atai Therapeutics, Inc. | Exploratory Safety and Efficacy of EMP-01 in Social Anxiety Disorder |
FDA applications (0)
No records yet.